Back to News
Market Impact: 0.5

Givaudan Q3 Sales Down, LFL Sales Rise; Still Expects To Exceed Average 5-year Sales Growth Target

NDAQ
Corporate EarningsCorporate Guidance & OutlookCompany Fundamentals
Givaudan Q3 Sales Down, LFL Sales Rise; Still Expects To Exceed Average 5-year Sales Growth Target

Givaudan AG reported a 1.5% decline in third-quarter sales to CHF 1.88 billion, primarily driven by weakness in its Taste & Wellbeing segment, though like-for-like (LFL) sales still grew 4.4%. Fragrance & Beauty sales increased 6.8% LFL, while Taste & Wellbeing saw a 2.1% LFL rise. For the first nine months, sales increased 1.7% to CHF 5.74 billion, or 5.7% LFL, and the company reiterated its expectation to exceed the upper end of its 4-5% LFL organic sales growth target for the 2021-2025 strategic cycle.

Analysis

Givaudan AG reported a 1.5% decline in third-quarter sales to CHF 1.88 billion, primarily due to reported weakness in its Taste & Wellbeing segment. However, underlying performance remains robust, with like-for-like (LFL) sales growing a solid 4.4% for the quarter, indicating strong organic demand despite currency headwinds or divestitures. The Fragrance & Beauty division demonstrated significant strength, achieving 6.8% LFL sales growth to CHF 968 million. Conversely, the Taste & Wellbeing segment experienced a 4.3% reported sales decrease, yet still managed a 2.1% LFL increase, suggesting that while reported figures were impacted, underlying demand in this segment also grew. For the first nine months, Givaudan's sales increased 1.7% to CHF 5.74 billion, with LFL growth reaching 5.7%. The company reiterated its optimistic outlook, stating it is "highly likely to exceed the upper end" of its 4-5% LFL organic sales growth target for the 2021-2025 strategic cycle, reinforcing confidence in its long-term trajectory.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.55

Ticker Sentiment

NDAQ0.00

Key Decisions for Investors

  • Investors should focus on Givaudan's consistent like-for-like sales growth and reaffirmed long-term guidance, which signal underlying business strength despite reported Q3 sales decline
  • Monitor the Taste & Wellbeing segment for signs of recovery in reported sales, as its current reported weakness is masking stronger LFL performance
  • Evaluate the company's ability to exceed its 4-5% LFL organic growth target for 2021-2025, as this provides a strong foundation for future value creation